ITRM930399A0 - Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee. - Google Patents

Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.

Info

Publication number
ITRM930399A0
ITRM930399A0 IT93RM399A ITRM930399A ITRM930399A0 IT RM930399 A0 ITRM930399 A0 IT RM930399A0 IT 93RM399 A IT93RM399 A IT 93RM399A IT RM930399 A ITRM930399 A IT RM930399A IT RM930399 A0 ITRM930399 A0 IT RM930399A0
Authority
IT
Italy
Prior art keywords
carnitine
acil
treatment
pharmaceutical compositions
skin diseases
Prior art date
Application number
IT93RM399A
Other languages
English (en)
Inventor
Claudio Cavazza
Paolo Cavazza
Original Assignee
Avantgarde Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avantgarde Spa filed Critical Avantgarde Spa
Publication of ITRM930399A0 publication Critical patent/ITRM930399A0/it
Priority to ITRM930399A priority Critical patent/IT1261984B/it
Priority to US08/254,766 priority patent/US5627212A/en
Priority to CA002125238A priority patent/CA2125238A1/en
Priority to ES94108921T priority patent/ES2107707T3/es
Priority to EP94108921A priority patent/EP0631779B1/en
Priority to AT94108921T priority patent/ATE157003T1/de
Priority to DK94108921.1T priority patent/DK0631779T3/da
Priority to DE69405054T priority patent/DE69405054T2/de
Priority to KR1019940013698A priority patent/KR950000142A/ko
Priority to ZA944413A priority patent/ZA944413B/xx
Priority to JP6139939A priority patent/JPH0710820A/ja
Publication of ITRM930399A1 publication Critical patent/ITRM930399A1/it
Application granted granted Critical
Publication of IT1261984B publication Critical patent/IT1261984B/it
Priority to GR970402509T priority patent/GR3024866T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
ITRM930399A 1993-06-22 1993-06-22 Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee. IT1261984B (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ITRM930399A IT1261984B (it) 1993-06-22 1993-06-22 Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
US08/254,766 US5627212A (en) 1993-06-22 1994-06-06 Esters of L-carnitine and acyl L-carnitine with hydoxy acids for producing pharmcaeutical compositions for treating dermatoses
CA002125238A CA2125238A1 (en) 1993-06-22 1994-06-06 Use of esters of l-carnitine and acyl l-carnitine with hydroxyacids for producing pharmaceutical compositions for treating dermatoses
DK94108921.1T DK0631779T3 (da) 1993-06-22 1994-06-10 Anvendelse af estere af L-carnitin og acyl-L-carnitin med hydroxysyrer til fremstilling af farmaceutiske præparater til behandling af hudlidelser.
EP94108921A EP0631779B1 (en) 1993-06-22 1994-06-10 Use of esters of L-carnitine and acyl L-carnitine with hydroxyacids for producing pharmaceutical compositions for treating dermatoses
AT94108921T ATE157003T1 (de) 1993-06-22 1994-06-10 Verwendung von l-carnitin- und acyl-l- cernitinestern mit hydroxysäuren zur herstellung pharmazeutischer zusammensetzungen zur behandlung der dermatosen
ES94108921T ES2107707T3 (es) 1993-06-22 1994-06-10 Empleo de esteres de l-carnitina y acil l-carnitina con hidroxiacidos para produccion de composiciones farmaceuticas para el tratamiento de dermatosis.
DE69405054T DE69405054T2 (de) 1993-06-22 1994-06-10 Verwendung von L-carnitin- und Acyl-L-cernitinestern mit Hydroxysäuren zur Herstellung pharmazeutischer Zusammensetzungen zur Behandlung der Dermatosen
KR1019940013698A KR950000142A (ko) 1993-06-22 1994-06-17 피부질환치료용 약제조성물 제조에 사용되는 히드록시산함유 l-카르니틴에스테르 및 아실 l-카르니틴에스테르의 용도
ZA944413A ZA944413B (en) 1993-06-22 1994-06-21 Use of o-esters of l-carnitine and acyl l-carnitine with hydroxyacids for producing pharmaceutical compositions for treating dermatoses
JP6139939A JPH0710820A (ja) 1993-06-22 1994-06-22 Ｌ−カルニチン類とヒドロキシ酸のエステルおよび皮膚病処置用医薬組成物
GR970402509T GR3024866T3 (en) 1993-06-22 1997-09-25 Use of esters of L-carnitine and acyl L-carnitine with hydroxyacids for producing pharmaceutical compositions for treating dermatoses.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM930399A IT1261984B (it) 1993-06-22 1993-06-22 Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.

Publications (3)

Publication Number Publication Date
ITRM930399A0 true ITRM930399A0 (it) 1993-06-22
ITRM930399A1 ITRM930399A1 (it) 1994-12-22
IT1261984B IT1261984B (it) 1996-06-11

Family

ID=11401814

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM930399A IT1261984B (it) 1993-06-22 1993-06-22 Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.

Country Status (12)

Country Link
US (1) US5627212A (it)
EP (1) EP0631779B1 (it)
JP (1) JPH0710820A (it)
KR (1) KR950000142A (it)
AT (1) ATE157003T1 (it)
CA (1) CA2125238A1 (it)
DE (1) DE69405054T2 (it)
DK (1) DK0631779T3 (it)
ES (1) ES2107707T3 (it)
GR (1) GR3024866T3 (it)
IT (1) IT1261984B (it)
ZA (1) ZA944413B (it)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1272290B (it) * 1994-06-20 1997-06-16 Avantgarde Spa Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
US6630442B1 (en) * 1997-01-10 2003-10-07 Theodore Hersh Reparatives for chemosurgery and laser (thermal) therapy
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6138683A (en) * 1997-09-19 2000-10-31 Thione International, Inc. Smokeless tobacco products containing antioxidants
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
US5922346A (en) * 1997-12-01 1999-07-13 Thione International, Inc. Antioxidant preparation
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
DE19806889A1 (de) * 1998-02-19 1999-08-26 Beiersdorf Ag Verwendung von Acyl-Carnitin
ES2210705T5 (es) 1998-03-19 2011-02-15 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Composición combinada que comprende una l-carnitina o una alcanoil-l-carnitina, un glucosaminoglucano y/o un constituyente del mismo.
IT1306129B1 (it) * 1999-04-13 2001-05-30 Sigma Tau Ind Farmaceuti Esteri della l-carnitina o di alcanoil l-carnitine utilizzabili comelipidi cationici per l'immissione intracellulare di composti
FI111686B (fi) * 2000-04-20 2003-09-15 Simo Rasi Kosmeettinen tai ihonhoidollinen voidekoostumus, sen valmistusmenetelmä ja käyttö
US6649176B1 (en) 2000-06-29 2003-11-18 Johnson & Johnson Consumer Companies, Inc. Compositions containing mineral water
US6432424B1 (en) 2000-06-29 2002-08-13 Johnson & Johnson Consumer Companies, Inc. Cosmetic compositions containing creatine, carnitine, and/or pyruvic acid
US6372791B1 (en) 2000-06-29 2002-04-16 Johnson & Johnson Consumer Companies, Inc. Method of promoting skin cell metabolism
US6630175B1 (en) 2000-06-29 2003-10-07 Johnson & Johnson Consumer Companies, Inc. Method of reducing eye irritation
EP1610760A4 (en) * 2003-03-28 2008-01-09 Lonza Ag TOPICAL COMPOSITIONS OF L-CARNITINE
AU2009223222A1 (en) 2008-03-13 2009-09-17 Perkinelmer Health Sciences, Inc. Enzymatic substrates for multiple detection systems
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
US9259343B2 (en) 2012-07-06 2016-02-16 Newman Technologies LLC Device for mitigating plantar fasciitis
CA2906839A1 (en) 2013-03-15 2014-09-18 Perkinelmer Health Sciences, Inc. Compounds and methods relating to testing for lysosomal storage disorders
CN116568292A (zh) * 2020-11-05 2023-08-08 莱托生物股份有限公司 用于治疗皮肤病症的新组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51148042A (en) * 1975-06-14 1976-12-18 Kanebo Ltd Skin toiletry
US4839159A (en) * 1988-02-08 1989-06-13 Topicarn, Inc. Topical L-carnitine composition
IT1238344B (it) * 1989-10-20 1993-07-13 Sigma Tau Ind Farmaceuti Estere della l-carnitina con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che lo contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma
FR2654619B1 (fr) * 1989-11-23 1992-01-31 Sederma Sa Utilisation en cosmetique de composes destines a optimiser la penetration des principes actifs.
FR2654618B1 (fr) * 1989-11-23 1994-04-29 Sederma Sa Utilisation en cosmetique de principes actifs destines a reguler la multiplication cellulaire.
IT1240760B (it) * 1990-02-12 1993-12-17 Sigma Tau Ind Farmaceuti Esteri di acil-l-carnitine con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che li contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma.
IT1240775B (it) * 1990-02-23 1993-12-17 Sigma Tau Ind Farmaceuti Esteri della l-carnitina e di acil-l-carnitine con l'acido beta-idrossibutirrico e composizioni farmaceutiche che li contengono per la inibizione della degenerazione neuronale, della proteolisi epatica e nel trattamento del coma.
IT1248321B (it) * 1991-05-15 1995-01-05 Sigma Tau Ind Farmaceuti Uso di esteri di acil l-carnitine con l'acido gamma-idrossibutirrico per produrre composizioni farmaceutiche per il trattamento di epatopatie
IT1263013B (it) * 1992-10-20 1996-07-23 Avantgarde Spa Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee.

Also Published As

Publication number Publication date
IT1261984B (it) 1996-06-11
EP0631779A1 (en) 1995-01-04
ATE157003T1 (de) 1997-09-15
GR3024866T3 (en) 1998-01-30
ES2107707T3 (es) 1997-12-01
KR950000142A (ko) 1995-01-03
US5627212A (en) 1997-05-06
DE69405054D1 (de) 1997-09-25
ITRM930399A1 (it) 1994-12-22
EP0631779B1 (en) 1997-08-20
CA2125238A1 (en) 1994-12-23
DK0631779T3 (da) 1997-09-15
JPH0710820A (ja) 1995-01-13
DE69405054T2 (de) 1997-12-18
ZA944413B (en) 1995-02-15

Similar Documents

Publication Publication Date Title
ITRM930399A0 (it) Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
ITRM930356A0 (it) Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
ITRM920761A0 (it) Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee.
FI980822A7 (fi) Farmaseuttinen koostumus vaikuttavan aineen iho- tai limakalvopintaan tai iho- tai limakalvopinnan läpi
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
RU94000061A (ru) Эфиры холестерина и ненасыщенных жирных кислот, способ лечения и фармацевтическая или косметическая композиция
FI962154L (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
IT8648358A0 (it) Impiego di acetil l-carnitina nel trattamento terapeutico delle neuropatie periferiche
ITRM940396A0 (it) Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee
ITMI981586A0 (it) Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose
ITRM930365A0 (it) Uso di esteri sull'ossidrile della l-carnitina con acidi aromatici perprodurre composizioni farmaceutiche per il trattamento di affezioni cutanee.
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
DK0871438T3 (da) Anvendelse af alfa-hydroxysyrer ved fremstillingen af et medikament til behandling af inflammation
ITRM910327A0 (it) Uso di esteri di acil l-carnitine con l'acido gamma-idrossibutirrico per produrre composizioni farmaceutiche per il trattamento di epatopatie.
ITRM920222A0 (it) Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
IT1274157B (it) "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"
IT9020968A0 (it) Metodi e composizioni farmaceutiche per il trattamento di malattie oftalmiche
ITMI950532A0 (it) Derivato di aminotetralina per la terapia di malattie cardiovascolari
FI904475A7 (fi) Tymopentiiniä sisältävät koostumukset ihosairauksien hoitamiseksi paik allisesti
DE68908414D1 (de) Pharmazeutische zusammensetzungen fuer die reizung eines immunostimulierenden effektes.
ITTO930024A0 (it) Composizione per accelerare la rimarginazione di ferite
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
ITRM930154A0 (it) Uso di terbinafina per il trattamento terapeutico della pneumocistosi.
SE8304331D0 (sv) Arzneimittel mit analgetischer wirkung
ITRM930412A0 (it) Uso di acil l-carnitine gamma-idrossibutirrato per il trattamento di tossicodipendenze.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970517